Building Patient Engagement and Secure Drug Discovery - Data Privacy, Compliance, and Security

January 22, 2020

This article originally appears in European Biopharmaceutical Review January 2020, pages 60-62. © Samedan Ltd

Much has been made of the trials and tribulations of complying with data regulations; however, Paul Drake at Signant Health argues there may be significant opportunities to be gained for clinical trials from data compliance.

Previous Video
Selecting and Implementing Mobile Sensors to Collect Clinical Trial Endpoint Data
Selecting and Implementing Mobile Sensors to Collect Clinical Trial Endpoint Data

In this webinar learn how to select a device that is acceptable to regulators and patients, implement mobil...

Next Article
Signant Health finds growing eConsent adoption forecasts and the importance of eClinical integration in latest “State of eConsent” survey
Signant Health finds growing eConsent adoption forecasts and the importance of eClinical integration in latest “State of eConsent” survey

Signant Health released the findings from its latest “State of eConsent” report, highlighting the sentiment...